D-1042-2018 Class II Terminated

Recalled by Morton Grove Pharmaceuticals, Inc. — Morton Grove, IL

FDA drug recall D-1042-2018 was initiated by Morton Grove Pharmaceuticals, Inc. on Jul 24, 2018 and is designated Class II. Reason for recall: Defective Container: Tamper Evident foil seal not completely intact. The recall status is terminated (terminated Sep 9, 2022). Affected quantity: 38,280 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 15, 2018
Initiation Date
Jul 24, 2018
Termination Date
Sep 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
38,280 bottles

Product description

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, 8 fl oz (237 mL) Bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-212-08.

Reason for recall

Defective Container: Tamper Evident foil seal not completely intact.

Distribution pattern

U.S. Nationwide

Code information

Lot US1259

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1042-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1042-2018. Report a data issue: hello@regdatalab.com.